drug · antibody
patient view →nemolizumab
Phase 2updated 2mo agoby Galderma SA🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 2 investigational indications.
targets
Interleukin-31 receptor subunit alpha
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that